What is Sleeve Gastrectomy?
Clinician's Perspective:
• Mechanical Restriction: The procedure involves the surgical removal of approximately 80% of the stomach, leaving a narrow, tubular "sleeve" about the size of a banana.
• Hormonal Modulation: Beyond physical size, the surgery significantly reduces the production of hunger-regulating hormones, which helps suppress appetite and cravings.
• Weight Loss Efficacy: Clinical data indicates that patients typically achieve a weight loss of 25% to 30% of their total body weight within the first 12 to 24 months post-operation.
• Safety Profile: The risk of major surgical complications is documented at less than 1%, a rate lower than that of common procedures like gallbladder removal or hip replacement.
• Disease Resolution: The intervention is recognized for its ability to improve or eliminate obesity-related comorbidities, including Type 2 diabetes and hypertension (high blood pressure).
• Long-term Maintenance: Success requires lifelong adherence to a healthy lifestyle.
The Gastric Sleeve, clinically referred to as a Sleeve Gastrectomy, has emerged as the most frequently performed weight loss surgery globally, with approximately 380,000 procedures conducted annually. It is typically performed by laparoscopic surgery, commonly known as "keyhole surgery". Unlike more complex bypass procedures, this operation focuses on altering the stomach’s architecture to address Adiposity (the state of having too much body fat) through two primary mechanisms: volume restriction and hormonal signaling.
The Physiological Mechanism
During the procedure, surgeons utilize minimally invasive laparoscopic or robotic techniques to divide the stomach. By removing the large, outer curved portion of the organ, the remaining gastric capacity is restricted to a narrow sleeve. This significantly limits the volume of food an individual can ingest before reaching satiety (the feeling of being full).
Furthermore, the portion of the stomach removed is responsible for producing a significant amount of the body’s hunger-inducing hormones. By reducing these chemical signals, the procedure helps mitigate the biological "drive" to eat, which often thwarts traditional weight loss efforts. This dual action—mechanical and chemical—contributes to the stabilization of blood glucose levels and the resolution of Insulin Resistance (a condition where the body's cells do not respond normally to insulin).
Clinical Indications and Outcomes
In Asia, sleeve gastrectomy may be indicated in individuals with Class III Obesity (a BMI of 35.0 or higher) or those with a BMI of at least 30.0 who also present with serious comorbidities. These related conditions often include Hyperlipidemia (high levels of fats or cholesterol in the blood) and Obstructive Sleep Apnea (a disorder where breathing repeatedly stops and starts during sleep). Patients with a BMI of 27.5 or more, and Type 2 diabetes may benefit from this surgery as well.
Data reveals that the average weight loss remains consistent at 25% to 30% of total body weight over a five-year period. For a patient weighing 100kg, this equates to a sustained loss of roughly 25kg to 30kg.
Risks and Post-Surgical Management
While the procedure is statistically safe, it is irreversible. Post-operative recovery involves a phased transition from liquids to soft foods, eventually returning to solids over several weeks. Some patients may experience Gastroesophageal Reflux (the backflow of stomach acid into the esophagus) or develop Gallstones (hardened deposits of digestive fluid) due to the rapid rate of weight loss.
Because the stomach’s volume is permanently reduced, patients must be vigilant against Sarcopenia (the age-related loss of muscle mass and strength) by ensuring adequate protein intake and lifelong vitamin supplementation. The goal is to treat the body as a high-performance system that requires precision fueling to maintain the metabolic advantages gained from the surgery.
